Effects of Pregnancy and Delivery on Disease Activity in Multiple Sclerosis
- 30 July 1998
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 339 (5) , 339-340
- https://doi.org/10.1056/nejm199807303390509
Abstract
Multiple sclerosis, an organ-specific autoimmune disease of the central nervous system, affects 250,000 to 350,000 persons in the United States. It is at least twice as common among women as among men — a sex distribution common to most autoimmune diseases. The clinical manifestations of multiple sclerosis reflect its multifocal involvement, and its course may be subacute, with relapses followed by remissions, or chronic and progressive.1 The diagnosis can be established with different degrees of confidence as probable or definite on the basis of clinical features alone or clinical features in combination with oligoclonal abnormalities of immunoglobulins in cerebrospinal fluid, . . .Keywords
This publication has 10 references indexed in Scilit:
- Rate of Pregnancy-Related Relapse in Multiple SclerosisNew England Journal of Medicine, 1998
- Current immunotherapy in multiple sclerosisImmunology & Cell Biology, 1998
- Axonal Transection in the Lesions of Multiple SclerosisNew England Journal of Medicine, 1998
- Pregnancy and Multiple SclerosisMayo Clinic Proceedings, 1997
- Defining the clinical course of multiple sclerosisNeurology, 1996
- Copolymer 1Neurology, 1995
- Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon?Immunology Today, 1993
- Twin studies and multiple sclerosisAnnals of Neurology, 1992
- Use of magnetic resonance imaging in the diagnosis of multiple sclerosisNeurology, 1986
- CLINICAL VIRAL INFECTIONS AND MULTIPLE SCLEROSISThe Lancet, 1985